Great Place To Work®, the global authority on workplace culture, has today announced that Viral Vector Manufacturing Facility Pty Ltd (VVMF) has been named as one of ten Australia’s Best Workplaces™ in Biotechnology & Pharmaceutical for 2026.
VVMF finds itself in elite company, with the honourees ranging from global pharmaceutical and medical technology companies to specialists in biotech and clinical research. Each organisation earned its place through confidential employee feedback collected in the Great Place To Work Trust Index™ survey. The results reflect what employees report about their everyday experience at work, not what the organisation says about itself. VVMF congratulates all the companies recognised in this category.
A Fast-Growing Sector
Australia’s life sciences sector has doubled in size since 2017. It now includes around 3,000 organisations and supports one in every 65 jobs nationwide, according to reports released by AusBiotech and Austrade in May 2026. Austrade puts the sector’s workforce at around 264,000 people, with at least 70% holding an advanced diploma or higher qualification. VVMF is proud to a member of this sector, supporting Australia’s national ambitions in advanced manufacturing, and focused on building sovereign industrial capabilities, driving high-tech innovation, and creating resilient, high-skilled jobs through initiatives like the Future Made in Australia framework. Highly engaged teams are critical to this success.
Stephen Thompson, VVMF CEO said: “We are incredibly proud to be recognised as one of Australia’s Best Workplaces in Biotechnology and Pharmaceutical for 2026. This achievement reflects the culture our people have built together, one founded on shared purpose, collaboration, respect and a genuine commitment to helping each other succeed. As VVMF continues to grow, we remain focused on creating an environment where people feel valued, empowered and connected to the meaningful work we do every day to advance life-changing therapies for patients.”
